- Home
- JANX vs NBHC Comparison
JANX vs NBHC Comparison
Compare JANX & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- NBHC
- Stock Information
- Founded
- JANX 2017
- NBHC 2009
- Country
- JANX United States
- NBHC United States
- Employees
- JANX N/A
- NBHC N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- NBHC Major Banks
- Sector
- JANX Health Care
- NBHC Finance
- Exchange
- JANX Nasdaq
- NBHC Nasdaq
- Market Cap
- JANX 1.6B
- NBHC 1.4B
- IPO Year
- JANX 2021
- NBHC 2012
- Fundamental
- Price
- JANX $23.60
- NBHC $35.85
- Analyst Decision
- JANX Strong Buy
- NBHC Hold
- Analyst Count
- JANX 7
- NBHC 5
- Target Price
- JANX $94.29
- NBHC $46.80
- AVG Volume (30 Days)
- JANX 808.2K
- NBHC 183.9K
- Earning Date
- JANX 08-06-2025
- NBHC 07-22-2025
- Dividend Yield
- JANX N/A
- NBHC 3.22%
- EPS Growth
- JANX N/A
- NBHC N/A
- EPS
- JANX N/A
- NBHC 2.89
- Revenue
- JANX $9,336,000.00
- NBHC $389,883,000.00
- Revenue This Year
- JANX N/A
- NBHC $12.13
- Revenue Next Year
- JANX $1,470.82
- NBHC $6.96
- P/E Ratio
- JANX N/A
- NBHC $12.45
- Revenue Growth
- JANX 28.12
- NBHC N/A
- 52 Week Low
- JANX $22.48
- NBHC $32.83
- 52 Week High
- JANX $71.71
- NBHC $51.76
- Technical
- Relative Strength Index (RSI)
- JANX 41.60
- NBHC 42.54
- Support Level
- JANX $24.45
- NBHC $35.52
- Resistance Level
- JANX $27.28
- NBHC $37.93
- Average True Range (ATR)
- JANX 1.35
- NBHC 0.61
- MACD
- JANX -0.09
- NBHC -0.13
- Stochastic Oscillator
- JANX 22.20
- NBHC 13.69
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About NBHC National Bank Holdings Corporation
National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.